H. Lundbeck A/S (Lundbeck) announced the appointment of Maria Alfaiate to the newly established role of EVP, Commercial and Corporate Strategy. Maria will join Lundbeck on 1 August 2024 and will be part of the Executive Management team. Maria Alfaiate will be responsible for strengthening corporate strategic functions and enhancing global marketing efforts.

Her focus will be on optimizing Lundbeck's ability to capitalize on both present and future opportunities. Maria brings significant experience from the life science and pharmaceutical sectors globally. Her expertise in developing strategic plans and executing programs to deliver state-of-the-art solutions for patients across diverse markets will play a pivotal role in shaping Lundbeck's future growth.

Maria joins Lundbeck from Bayer where she recently served as Senior Vice President and Global Head of New Products Commercialization and Portfolio Strategy. Prior to this, Maria has held positions at AstraZeneca and MSD/Merck, in global teams but also at country level. Maria is of Portuguese nationality and holds a Master of Clinical Psychology from Universidade de Coimbra, Portugal.